New drug troriluzole tested in brain tumor surgery window
Disease control
Recruiting now
This early-phase trial tests the drug troriluzole in 27 adults with recurrent glioblastoma, a type of aggressive brain tumor. Participants take the drug before surgery to see how it affects brain activity and glutamate levels in the tumor. The goal is to gather information for fu…
Phase: EARLY_PHASE1 • Sponsor: Ugonma Chukwueke • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC